Delivery Order SPE2DB24D2212-SPE2DB25FHPPD
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX4UG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120 per bottle. It is a firm-fixed-price delivery order contract with a ceiling value of $19,431.45 and a period of performance through November 1, 2024. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablet 120S. The $1,541.04 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, with ID SPE2DB22D3010|SPE2DB25FP1SW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120s, with a total ceiling value of $10,090.83. It is a firm-fixed-price delivery order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562539132 - Mesalamine DR 1.2 GM Tablet 120S, a pharmaceutical product. The contract has a ceiling value of $4,638.26 and a period of performance through October 20, 2023. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,205.60, is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120. The contract is a Firm Fixed Price Delivery Order with a performance period ending on March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,793,798 units of the drug Mesalamine DR 1.2 GM Tablet 120S, with a ceiling value of $3,303.88. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 4, 2025. This award is not designated as a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablets. The contract has a ceiling value of $1,810.32 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZCQ, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to the prime contractor Amerisourcebergen Drug Corp. The $12,756.40 firm fixed-price delivery order is for the procurement of 4,563,239,385 units of the drug Mesalamine DR 1.2 GM Tablet in 120-count packages. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,481.85, is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120. The contract has a period of performance through March 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.36, is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release (DR) tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of March 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...